Krystal Biotech to Present at Guggenheim Securities Healthcare Innovation Conference
Krystal Biotech (NASDAQ: KRYS) has announced its participation in the upcoming Guggenheim Securities Healthcare Innovation Conference in Boston on November 12, 2024. Krish S. Krishnan, Chairman and CEO, will participate in a fireside chat at 1:30 pm ET and conduct investor meetings throughout the day. The presentation will be accessible via webcast and will be available on the company's Investors section of their website.
Krystal Biotech (NASDAQ: KRYS) ha annunciato la sua partecipazione al prossimo Guggenheim Securities Healthcare Innovation Conference che si terrà a Boston il 12 novembre 2024. Krish S. Krishnan, Presidente e CEO, parteciperà a una chiacchierata informale alle 13:30 ET e condurrà incontri con gli investitori per tutto il giorno. La presentazione sarà accessibile tramite webcast e sarà disponibile nella sezione Investitori del sito web dell'azienda.
Krystal Biotech (NASDAQ: KRYS) ha anunciado su participación en la próxima Conferencia de Innovación en Salud de Guggenheim Securities en Boston el 12 de noviembre de 2024. Krish S. Krishnan, Presidente y CEO, participará en una charla informal a la 1:30 p.m. ET y realizará reuniones con inversores durante todo el día. La presentación será accesible a través de un webcast y estará disponible en la sección de Inversores de su sitio web.
Krystal Biotech (NASDAQ: KRYS)가 2024년 11월 12일 보스턴에서 열리는 구겐하임 증권 헬스케어 혁신 컨퍼런스에 참여한다고 발표했습니다. Krish S. Krishnan 회장 겸 CEO는 오후 1시 30분 ET에 화톳불 토크에 참여하고 하루 종일 투자자 회의를 진행할 예정입니다. 발표는 웹캐스트를 통해 접근 가능하며, 회사 웹사이트의 투자자 섹션에서 확인할 수 있습니다.
Krystal Biotech (NASDAQ: KRYS) a annoncé sa participation à la prochaine Conférence sur l'Innovation en Santé de Guggenheim Securities à Boston le 12 novembre 2024. Krish S. Krishnan, Président et CEO, participera à une discussion informelle à 13h30 ET et mènera des réunions avec des investisseurs tout au long de la journée. La présentation sera accessible via un webdiffusion et sera disponible dans la section Investisseurs de leur site web.
Krystal Biotech (NASDAQ: KRYS) hat seine Teilnahme an der bevorstehenden Guggenheim Securities Healthcare Innovation Conference in Boston am 12. November 2024 bekannt gegeben. Krish S. Krishnan, Vorsitzender und CEO, wird um 13:30 Uhr ET an einem Gespräch am Kamin teilnehmen und den ganzen Tag über Investorenmeetings abhalten. Die Präsentation wird per Webcast zugänglich sein und im Bereich „Investoren“ auf der Website des Unternehmens verfügbar sein.
- None.
- None.
PITTSBURGH, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim Securities Healthcare Innovation Conference on November 12, 2024, in Boston. Krish S. Krishnan, Chairman and Chief Executive Officer, will take part in a fireside chat scheduled at 1:30 pm ET and host investor meetings throughout the day.
A webcast of the presentation will be available here beginning at 1:30 pm ET on Tuesday, November 12, 2024 and will be posted on the Investors section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK® is the Company’s first commercial product, the first-ever redosable gene therapy, and the first medicine approved by the FDA for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).
CONTACT
Investors and Media:
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com
FAQ
When is Krystal Biotech (KRYS) presenting at the Guggenheim Securities Healthcare Conference 2024?
Will the Krystal Biotech (KRYS) Guggenheim Conference presentation be available online?
What type of presentation will Krystal Biotech (KRYS) give at the Guggenheim Healthcare Conference?
